MedTrace Logo

Assessment of Thrombotic Status in Patients With Acute Coronary Syndrome

NCT02562690 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2016-05-11

No results posted yet for this study

Summary

Impaired thrombotic status is associated with adverse cardiovascular events. Patients with acute coronary syndrome (ACS) are at increased cardiovascular risk. The aim of the study is to determine the usefulness of thrombotic status assessment in a large cohort of ACS patients, managed with contemporary treatments, to identify patients at risk of thrombosis and those at risk of bleeding complications.

Conditions

  • Acute Coronary Syndrome

Interventions

OTHER

Thrombin generation assays, TEG and GTT

Thrombin generation assays, Thromboelastography (TEG), and Global Thrombosis Test (GTT)

Sponsors & Collaborators

  • East and North Hertfordshire NHS Trust

    collaborator OTHER_GOV

  • University of Hertfordshire

    lead OTHER

Principal Investigators

  • Prof. Diana A Gorog, MD, PhD · East and North Hertfordshire NHS Trust

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-03-31
Primary Completion
2020-02-29
Completion
2020-02-29

Countries

  • United Kingdom

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02562690 on ClinicalTrials.gov